Clinical TrialsSearch results
Number of results: 428
Other
- A non-randomized confirmatory study of Limited Surgical Resection for Peripheral Early Lung Cancer Defined with Thoracic Thin-section Computed Tomography (JCOG0804/WJOG4507L)
- small (2 cm or less) peripheral radiological non-invasive lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-05-26
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Other
- A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465)
- B-Cell Malignancies
- Ueda Eiji
- 2023-01-06
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 3 Study of LOXO-305 in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Masaki Takeshi
- 2021-08-24
Other
- A phase II randomized study of DP(Docetaxel+Cisplatin),DJ(Docetaxel+Carboplatin),and TJ(Paclitaxel+Carboplatin) in patients with advanced and recurrent endometrial carcinoma
- advanced or recurrent endometrial carcinoma
- Japanese Gynecologic Oncology Group
- 2005-09-15
Other
- A phase II randomized trial in completely resected Non-Small-Cell Lung Cancer comparing paclitaxel / carboplatin with docetaxel / cisplatin TORG0503
- Non-Small-Cell Lung Cancer
- Thoracic Oncology Research Group (TORG)
- 2008-07-11
Other
- A Phase II Study of Capecitabine plus Paclitaxel Combination Chemotherapy in Patients with Metastatic Breast Cancer
- Metastatic Breast Cancer
- KBCSG (Kinki Breast Cancer Study Group)
- 2007-10-30
Other
- A phase II study of ipilimumab, nivolumab, and radiotherapy for advanced NSCLC
- Non-small cell lung cancer
- Miyauchi Eisaku
- 2022-04-19
Other
- A phase II study of Irinotecan (CPT-11) for Leiomyosarcoma of Uterus
- Leiomyosarcoma of Uterus
- Japanese Gynecologic Oncology Group
- 2006-07-13